Schroder Investment Management Group
TNGX icon

Schroder Investment Management Group’s Tango Therapeutics TNGX Stock Holding History

Schroder Investment Management Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.07M Buy
278,511
+71,007
+34% +$1.76M 0.01% 688
2026
Q1 		$3.99M Buy
+207,504
New +$2.89M ﹤0.01% 818
2025
Q2 		– Sell
-655,158
Closed -$963K – 1236
2025
Q1 		$963K Hold
655,158
– – ﹤0.01% 993
2024
Q4 		$2.03M Buy
+655,158
New +$3.04M ﹤0.01% 919

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Schroder Investment Management Group's TNGX Position: Q2 2026 in Review

Schroder Investment Management Group increased its Tango Therapeutics (TNGX) stake by 34% in Q2 2026, buying an estimated $1.76M and bringing the position to 278,511 shares worth $9.07M. The position accounts for 0.01% of the portfolio, ranked #688.

Schroder Investment Management Group first reported a position in TNGX in Q4 2024 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Schroder Investment Management Group held 278,511 shares of Tango Therapeutics worth $9.07M as of Q2 2026.
  • Schroder Investment Management Group bought 71,007 Tango Therapeutics shares in Q2 2026, an estimated $1.76M.
  • Tango Therapeutics made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #688 holding.
  • Schroder Investment Management Group first reported a position in Tango Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.